Back to Search Start Over

Quercetin/Polyethyleneimine Modified Gold Nanoconjugates Inhibit Apoptosis and ROS Production Induced by Hydrogen Peroxide in DRG Sensory Neurons.

Authors :
Ozcicek I
Baydas G
Erim UC
Ustundag UV
Source :
Journal of pharmaceutical sciences [J Pharm Sci] 2024 Oct; Vol. 113 (10), pp. 3088-3099. Date of Electronic Publication: 2024 Aug 14.
Publication Year :
2024

Abstract

The basis of most neurological syndromes is the accumulation of free radical molecules. Quercetin is a polyphenolic bioflavonoid molecule and it has a very strong antioxidant effect by maintaining oxidative balance. There are many difficulties in the clinical use of quercetin due to its hydrophobic structure, low solubility, instability, poor oral bioavailability, and limited tissue-barrier penetration. Its synergistic use in complex with gold nanoparticles (AuNPs) could overcome these problems. AuNPs have recently emerged as an attractive candidate for delivery applications of various biomolecules and drugs. The aim of this study was to synthesize two different sized gold nanoparticles (AuNP <subscript>20</subscript> and AuNP <subscript>50</subscript> ) modified with polyethyleneimine (PEI) and quercetin, evaluate their potential neuroprotective effects on the in vitro oxidative stress model using DRG primary sensory neurons. It was shown that the antioxidant and anti-apoptotic ability of the bioflavonoid was preserved after exposure to the designed quercetin modified AuNPs. The PEI surface coating increased the stability and biocompatibility of the AuNPs in both sizes. It also potentially enables additional surface functionalization. This study indicates that designed nanoparticles (AuNP-Q-PEI) with different sizes could be a useful potential platform for the treatment of neurodegenerative syndromes or cancer diseases.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1520-6017
Volume :
113
Issue :
10
Database :
MEDLINE
Journal :
Journal of pharmaceutical sciences
Publication Type :
Academic Journal
Accession number :
39151794
Full Text :
https://doi.org/10.1016/j.xphs.2024.08.008